Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
J Allergy Clin Immunol
; 152(6): 1470-1492, 2023 12.
Article
en En
| MEDLINE
| ID: mdl-37678577
Palabras clave
Atopic dermatitis (eczema); Janus kinase (JAK) inhibitors (upadacitinib, abrocitinib, baricitinib), patient-important outcomes and adverse events or adverse reactions, disease severity, itch, sleep, itch and sleep disturbance quality of life; network meta-analysis (comparative effectiveness, multiple treatment comparison); systemic treatments and phototherapy (light therapy, immunosuppressants, immunomodulators, DMARDs, cyclosporine, methotrexate, azathioprine, mycophenolate, cortiosteroids, narrow-band UVB), biologics (dupilumab, lebrikizumab, tralokinumab, nemolizumab)
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Asma
/
Dermatitis Atópica
/
Eccema
Tipo de estudio:
Clinical_trials
/
Guideline
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
J Allergy Clin Immunol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Canadá